10th Jan 2022 13:45
(Alliance News) - Renalytix PLC said on Monday that it has partnered with Singing River Health System to improve kidney health in Mississippi through its KidneyIntelX platform.
The London-based diagnostics company focused on the management of kidney disease said the partnership will deploy its KidneyIntelX informed care management to improve kidney health in individuals with type 2 diabetes and early-stage chronic kidney disease.
The KidneyIntelX platform enables Singing River's primary and speciality care providers to identify and understand a person's kidney health risks, implement medication and nutrition management, and provide educational intervention, Renalytix explained.
Singing River and Renalytix will focus on improving health outcomes and reducing healthcare costs in high-risk populations by driving early detection and providing informed care in seeking to delay disease progression and prevent unnecessary dialysis starts.
The partnership will be focussed on the Mississippi Gulf Coast in the US.
Tom McLain, president of Renalytix, said: "In addition to our new partnership with Singing River, we have secured provider agreements with 27 state Medicaid programs. We believe that precision medicine approaches, including KidneyIntelX, will ensure that the right treatment gets to the right patients, regardless of population type, economic status or health insurance coverage."
Shares in Renalytix were up 1.0% at 550.40 pence on Monday afternoon in London.
By Heather Rydings; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Renalytix Plc